Radiation therapy clinic software provider RaySearch Laboratories posted increased net sales of 293.3 million Swedish krona ($27.1 million U.S.) for its third-quarter and net sales of 869.4 million Swedish krona ($80.2 million) for the nine months.
For the period (end-September 30), the Stockholm, Sweden-based company posted a profit after tax of 45.4 million Swedish krona ($4.2 million), an increase of 110% over the same period last year.
For the nine months, RaySearch reported order intake valued at 782.1 million Swedish krona ($72.1 million), an increase of 14% over 2023, with a profit after tax of 143.5 million Swedish krona ($13.2 million U.S.), an increase of 187%.
RaySearch highlighted significant events during the period, including an order from the U.K.'s Genesis Care, more than 100 RayStation customers in China, and a new deal with the French Unicancer network.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
